Prevalence of hepatitis C virus among HIV-infected patients in Madrid;Prevalencia de hepatitis C en población infectada por el VIH en el área 2 de Madrid

Anales de Medicina Interna

Volumn 23, Issue 3, 2006, Pages 111-114

  Gonzalez Cerrajero M ^a   Pazos Garcia A ^a   De Los Santos Gil, Ignacio ^a   Sanz Sanz, J ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Hepatitis C; HIV; Prevalence

Indexed keywords

INTERFERON; RIBAVIRIN; ANTIVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROLOGY; COMORBIDITY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; DRUG UTILIZATION; EPIDEMIOLOGY; MIDDLE AGED; OUTPATIENT; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; SPAIN; STATISTICS; SUBSTANCE ABUSE; URBAN POPULATION; VIRUS LOAD;

ADULT; ALCOHOL DRINKING; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERONS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; QUESTIONNAIRES; RIBAVIRIN; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION; VIRAL LOAD;

EID: 33746820725     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Soriano V, González-Lahoz J. Coinfección por VIH y virus de la Hepatitis C. Publicaciones Permanyer; 2003.
2. Berenguer Berenguer J, López Bernaldo de Quiros JC, Clemente Ricote G. Hepatitis C en pacientes infectados por el virus de la inmunodeficiencia humana. Ediciones Ergon; 2002.
3. Núñez M, Martin-Carbonero L, Soriano V et al. Impact of hepatitis C virus (HCV) on morbidity and mortality rates among HIV-infected patients. Clin Infect Dis 2003;37: 460-461.
4. Borgia G, Reynaud L, Gentile I, et al. HIV and Hepatitis C: facts and controversies. Infection 2003; 31: 232-240.
5. González SA, Talal AH. Hepatitis C virus in human immunodeficiency virus- infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis 2003; 23: 149-166.
6. Spengler U, Rockstroch JK. Hepatitis C in the patient with human immunodeficiency Virus infection. J Hepatol 1998; 29: 1023-1030.
7. Khalili M, Behm BW. Hepatitis C in the setting of HIV coinfection. Microbes Infect 2002; 4: 1247-1251.
8. Strasfeld L, Lo Y, Netski D, et al. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Inmune Defic Syndr 2003; 33: 356-364.
9. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-Infected Person. Ann Intern Med 2003; 138; 197-207.
10. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-Infected patient. Clin Liver Dis 2003; 7: 179-194.
11. Maier I, Wu GY. Hepatitis C and HIV co-infection: a review. World J Gastroenterol 2002; 8: 577-579.
12. Roca B, Suárez I, González J, et al. Hepatitis C virus and human immunodeficiency virus coinfection in Spain. J Infect 2003; 47: 117-124.
13. Patrick DM, Tyndall MW, Cornelisse PG, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001; 165: 889-895.
14. Tedaldi EM, Baker RK, Moorman AC, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2003; 36: 363-367.
15. Martínez-Sierra C, Arizcorreta A, Diaz F, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003; 36: 491-498.
16. Bruno R, Sacchi P, Debiaggi M, et al. Prevalence and histological features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. Dig Liver Dis 2000; 32: 617-620.
17. Dodig M, Tavill AS. Hepatitis C and human immunodeficiency virus co-infections. J Clin Gastroenterol 2001; 33: 367-374.
18. Tedaldi EM, Hullsiek KH, Malvestutto CD, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 2003; 36: 1313-1317.
19. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C Virus prevalence among patients infected with human immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831-937.
20. Waldrep TW, Summers KK, Chiliade PA. Coinfection with HIV and HCV: more questions than answers? Pharmacotherapy 2000; 20: 1499-1507.
21. Buti M. Tratamiento con interferón de la hepatitis crónica por virus C en pacientes coinfectados por VIH. An Med Interna (Madrid) 2004; 21: 367-368.
22. Santos I, Sanz J. Tratamiento con interferón y ribavirina de la hepatitis crónica por virus C en pacientes con infección por VIH. An Med Interna (Madrid) 2004; 21: 369-372.
23. Pérez ML, Álvarez A, Fuertes A. Tratamiento de la infección crónica por VHC en pacientes coinfectados por el VIH. An Med Interna (Madrid) 2005; 22: 288-292.
24. López G. Tratamiento de la hepatitis crónica VHC en pacientes coinfectados por VIH. An Med Interna (Madrid) 2005; 22: 259-260.